Comparison of the effect gabapentin and pergabalin on hemodynamic changes during laryngoscopy and intubation in patients undergoing elective surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250701066312N1

Enrollment

Registered

2025-07-10

Start date

2025-07-08

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison of the effect gabapentin and pergabalin on hemodynamic changes during laryngoscopy and intubation in patients undergoing elective surgery in Bandar Abbas Shahid Mohammadi Hospital in 2024&2025.

Interventions

Intervention 1: Group A Gabapentin Capsule with 300mg orally of Mehrdaru Company. Intervention 2: Control group: Group C placebo orally. Intervention 3: Intervention group: Group B Pergabaline with 1

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients of 18-50 are studied.

Exclusion criteria

Exclusion criteria: The patient's dissatisfaction History of substance abuse High blood pressure history Emergency patients Patients with Drugs Patients receiving these drugs in advance

Design outcomes

Primary

Measure	Time frame
Changes of systolic blood pressure during laryngoscopy and intubation. Timepoint: -Before the induction of anesthesia - After the anesthesia induction -Immediately after the piping of the chip -1 and 3 and 5 minutes after the chip pipe. Method of measurement: The barometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Falsafi nia

Bandare-abbas University of Medical Sciences

Sarafalsafi6039@gmail.com+98 917 253 6039

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026